Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Mizuho Asada"'
Publikováno v:
Pharmaceuticals, Vol 16, Iss 10, p 1500 (2023)
Drug-induced pruritus triggers a desire to scratch, thereby diminishing one’s quality of life. Certain instances of this phenomenon follow complex mechanisms of action that diverge from histamine-mediated pathways, known contributors to pruritus. H
Externí odkaz:
https://doaj.org/article/a79ee55c6deb4bdd8817b419c39c35bc
Autor:
Yuka Mishima, MD, Nobutoshi Nawa, MD, PhD, Mizuho Asada, PhD, Michio Nagashima, MD, PhD, Yoshibumi Aiso, MPharm, Yoko Nukui, MD, PhD, Takeo Fujiwara, MD, PhD, Hidenobu Shigemitsu, MD
Publikováno v:
Critical Care Explorations, Vol 5, Iss 1, p e0837 (2023)
OBJECTIVES:. The antimicrobial stewardship program (ASP) is an important quality improvement initiative that is recommended in the ICU. However, the shortage of infectious disease physicians in Japan has led to the need for simpler methods for implem
Externí odkaz:
https://doaj.org/article/9ecae457be624a7499bb4130a474db7e
Publikováno v:
PLoS ONE, Vol 17, Iss 8 (2022)
With the progression of global vaccination against coronavirus disease 2019 (COVID-19), embolic and thrombotic events (ETEs) following COVID-19 vaccination continue to be reported. To date, most reports on the type of COVID-19 vaccine and ETEs have b
Externí odkaz:
https://doaj.org/article/0ad9079c032743219c2ffac152e13682
Autor:
Masayuki Chuma, Hirofumi Hamano, Takashi Bando, Masateru Kondo, Naoto Okada, Yuki Izumi, Shunsuke Ishida, Toshihiko Yoshioka, Mizuho Asada, Takahiro Niimura, Yoshito Zamami, Kenshi Takechi, Mitsuhiro Goda, Koji Miyata, Kenta Yagi, Sachiko Kasamo, Yuki Izawa‐Ishizawa, Momoyo Azuma, Hiroaki Yanagawa, Yoshikazu Tasaki, Keisuke Ishizawa
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. 131:525-535
There has been growing concern in worsening survival and renal outcomes following vancomycin-associated nephrotoxicity (VAN) onset, but the factors associated with these phenomena remain unclear. To examine these factors, we performed a retrospective
Autor:
Yoshihiro Uesawa, Masayuki Chuma, Takahiro Niimura, Keisuke Ishizawa, Mizuho Asada, Takahisa Mikami, Yoshito Zamami
Publikováno v:
Oncology. 99:256-259
Background: Pneumonitis is a serious adverse event in patients treated with immune checkpoint inhibitors (ICIs), with a mortality rate of up to 20%. The risk factors for ICI-related pneumonitis remain unclear due to the scarce data and infrequent eve
Autor:
Hirotoshi Echizen, Tokujiro Uchida, Hirokuni Arai, Tomohiro Mizuno, Koshi Makita, Mizuho Asada, Shinichi Kijima, Masato Yasuhara, Hiromitsu Takahashi, Masashi Nagata
Publikováno v:
European Journal of Clinical Pharmacology. 77:735-745
The aims of the present study were to establish a population pharmacokinetic (PPK) model of cefazolin for adult patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) and to assess the probability of target attainment (PTA) for the pro
Autor:
Masayuki Chuma, Aki Nakamoto, Takashi Bando, Takahiro Niimura, Yutaka Kondo, Hirofumi Hamano, Naoto Okada, Mizuho Asada, Yoshito Zamami, Kenshi Takechi, Mitsuhiro Goda, Koji Miyata, Kenta Yagi, Toshihiko Yoshioka, Yuki Izawa-Ishizawa, Hiroaki Yanagawa, Yoshikazu Tasaki, Keisuke Ishizawa
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 75(8)
Background There is a growing concern about the association between the combined use of daptomycin (DAP) and statins and the occurrence of musculoskeletal adverse events (MAEs), but this remains controversial. This study aimed to clarify the associat
Autor:
Takahisa Mikami, Akira Machida, Stanley Tuhrim, David E. Thaler, Matthew Harrington, Kiyohide Fushimi, Mizuho Asada, Norihiko Inoue
Publikováno v:
Stroke. 52
Objective: To investigate the timing of DOAC initiation to decrease mortality rate in the acute phase of cardioembolic stroke. Design: Retrospective observational study using a national administrative database. Setting: Japanese hospitals providing c
Autor:
Eisei Sohara, Shotaro Naito, Yasuyoshi Ishiwata, Moko Zeniya, Daiei Takahashi, Masashi Nagata, Shinichi Uchida, Norikazu Shoji, Soichiro Iimori, Yoshiyuki Numasawa, Tatemitsu Rai, Mizuho Asada, Naohiro Nomura, Hidehiko Sato, Tomokazu Okado, Soichiro Suzuki, Takanori Yokota
Publikováno v:
Internal Medicine
Encephalopathy is a rare side effect of cephalosporin treatment. We herein present a case of encephalopathy induced by ceftriaxone, a third-generation cephalosporin, in a patient with renal failure. An 86-year-old woman on maintenance hemodialysis re
Autor:
Takahisa, Mikami, Bobby, Liaw, Mizuho, Asada, Takahiro, Niimura, Yoshito, Zamami, Deborah, Green-LaRoche, Lori, Pai, Michael, Levy, Suriya, Jeyapalan
Publikováno v:
Journal of neuro-oncology. 152(1)
To investigate the characteristics and risk factors for neurologic adverse events (AEs) induced by immune checkpoint inhibitors (ICIs).An observational, retrospective, and pharmacovigilance study based on the FAERS database collected between January